021-51111890
购物车（）
sales@molnova.cn
(Z)-4-Hydroxytamoxifen
CAS No. 68047-06-3
(Z)-4-Hydroxytamoxifen ( trans-4-Hydroxytamoxifen )
产品货号. M15596 CAS No. 68047-06-3
A major metabolite of tamoxifen, a well-known Estrogen receptor antagonist in breast but partial estrogen receptor agonist in endometrium.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥518 | 有现货 |
|
| 10MG | ￥721 | 有现货 |
|
| 25MG | ￥1596 | 有现货 |
|
| 50MG | ￥3127 | 有现货 |
|
| 100MG | ￥4609 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称(Z)-4-Hydroxytamoxifen
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述A major metabolite of tamoxifen, a well-known Estrogen receptor antagonist in breast but partial estrogen receptor agonist in endometrium.
-
产品描述A major metabolite of tamoxifen, a well-known Estrogen receptor antagonist in breast but partial estrogen receptor agonist in endometrium; shows a 100-fold increased affinity for ER and approximately 100-times more potent than trans-tamoxifen in suppressing cell growth and plasminogen activator activity.
-
同义词trans-4-Hydroxytamoxifen
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体ER
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number68047-06-3
-
分子量387.51
-
分子式C26H29NO2
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 28 mg/mL
-
SMILESOC1=CC=C(/C(C2=CC=C(OCCN(C)C)C=C2)=C(C3=CC=CC=C3)\CC)C=C1
-
化学全称Phenol, 4-[(1Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Katzenellenbogen BS, et al. Cancer Res. 1984 Jan;44(1):112-9.
2. Desta Z, et al. J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75.
3. Crewe HK, et al. Drug Metab Dispos. 2002 Aug;30(8):869-74.
2. Desta Z, et al. J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75.
3. Crewe HK, et al. Drug Metab Dispos. 2002 Aug;30(8):869-74.
产品手册
关联产品
-
Diarylpropionitrile
Diarylpropionitrile (DPN) is a non-steroidal estrogen receptor β(ERβ) selective ligand.
-
Quinestrol
Quinestrol is a synthetic estrogen, used in hormone replacement therapy, and occasionally to treat breast cancer and prostate cancer.
-
Endoxifen
A metabolite of tamoxifen, orally active non-steroidal selective estrogen receptor modulator (SERM) for the treatment of estrogen receptor-positive breast cancer.
